Pioneering instrument to scan for cancer in resected prostate at surgery for relapse-free patients

Important results from the project

We have developed an instrument ProScan (patented) that can detect prostate cancer on the surface during surgery that has been tested on 10 whole resected prostate glands. In comparison with the golden standard, statistical analysis shows that our method may detect cancer as intended. We have also developed a demonstrator that shows the use of the instrument. We have developed an innovation that will save time in healthcare and reduce recurrence rates and suffering in prostate cancer patients.

Expected long term effects

The project has contributed to knowledge about the biomechanical and optical properties of the prostate gland and to an innovation, ProScan. The knowledge is important for determining tumor aggressiveness and surgical method! ProScan will enable the patient to be "cured" directly on the operating table meaning reduced suffering and saved economic costs. The project has contributed to increased knowledge about IPR strategy and project management that will influence future development projects.

Approach and implementation

The project was divided into 4 work packages (AP): Instrument development, Clinical validation, Business model and project management. A project group including medical and technical parties carried out the practical work and project meetings were held to reconcile milestones. A steering group was established where overall finances and project status were reported. The PI was responsible for coordinating the work in AP1-4. The schedule and AP were followed while the IPR showed some difficulties.